American Capital Advisory’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$59 – 1206
2026
Q2
$59 Hold
1
– – ﹤0.01% 1150
2026
Q1
$59 Buy
+1
New +$54 ﹤0.01% 1125

Other funds holding PCVX

American Capital Advisory's PCVX Position: Q3 2026 in Review

American Capital Advisory sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 1 share — an estimated $59 sold.

American Capital Advisory first reported a position in PCVX in Q1 2026 and held it in 2 quarters. The position peaked at $59 in Q2 2026. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • American Capital Advisory reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
  • American Capital Advisory sold 1 Vaxcyte share in Q3 2026, an estimated $59.
  • American Capital Advisory first reported a position in Vaxcyte in Q1 2026 and held it in 2 quarters.
  • American Capital Advisory's Vaxcyte position peaked at $59 in Q2 2026.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.